Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.60USD
16 Feb 2018
Change (% chg)

$0.21 (+15.11%)
Prev Close
$1.39
Open
$1.40
Day's High
$1.77
Day's Low
$1.40
Volume
820,546
Avg. Vol
114,842
52-wk High
$3.78
52-wk Low
$1.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.12 0.25 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 2 -0.22 -0.20 -0.24 --
Quarter Ending Jun-18 2 -0.25 -0.23 -0.26 --
Year Ending Dec-18 3 -1.06 -1.00 -1.17 -2.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) -- 110.72 5.77
Price to Book (MRQ) 2.60 13.56 5.41
Price to Tangible Book (MRQ) 2.60 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 37.97 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.92 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 27.59 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 3.72 5.30 2.97
LT Debt to Equity (MRQ) 3.86 22.82 12.22
Total Debt to Equity (MRQ) 19.07 24.47 16.52
Interest Coverage (TTM) -41.02 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -- -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -- -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -- -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,602,121 855,667,832
Net Income/Employee (TTM) -843,342 2,968,747 100,655,557
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.03 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -107.14 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -117.90 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -4.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.10%
# of Holders: 31
Total Shares Held: 9,255,491
3 Mo. Net Change: 658,880
# New Positions: 6
# Closed Positions: 6
# Increased Positions: 18
# Reduced Positions: 8
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.